Home Biotechnology Dried Blood Spot Collection Cards Market Size & Revenue Analysis by 2031

Dried Blood Spot Collection Cards Market Size, Share & Trends Analysis Report By Application (Newborn Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, CRO/Research), By Card Type (Whatman 903, Ahlstrom 226, FTA, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRBI55551DR
Last Updated: Nov, 2023
Pages: 110
Author: Dhanashri Bhapakar
Format: PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Dried Blood Spot Collection Cards Market Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Newborn Screening (NBS)
        1. By Value
      3. Infectious Diseases Testing
        1. By Value
      4. Therapeutic Drug Monitoring
        1. By Value
      5. Forensics
        1. By Value
      6. CRO/Research
        1. By Value
    3. By Card Type
      1. Introduction
        1. Card Type By Value
      2. Whatman 903
        1. By Value
      3. Ahlstrom 226
        1. By Value
      4. FTA
        1. By Value
      5. Others
        1. By Value
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Newborn Screening (NBS)
        1. By Value
      3. Infectious Diseases Testing
        1. By Value
      4. Therapeutic Drug Monitoring
        1. By Value
      5. Forensics
        1. By Value
      6. CRO/Research
        1. By Value
    3. By Card Type
      1. Introduction
        1. Card Type By Value
      2. Whatman 903
        1. By Value
      3. Ahlstrom 226
        1. By Value
      4. FTA
        1. By Value
      5. Others
        1. By Value
    4. U.S.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Newborn Screening (NBS)
          1. By Value
        3. Infectious Diseases Testing
          1. By Value
        4. Therapeutic Drug Monitoring
          1. By Value
        5. Forensics
          1. By Value
        6. CRO/Research
          1. By Value
      2. By Card Type
        1. Introduction
          1. Card Type By Value
        2. Whatman 903
          1. By Value
        3. Ahlstrom 226
          1. By Value
        4. FTA
          1. By Value
        5. Others
          1. By Value
    5. Canada
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Newborn Screening (NBS)
        1. By Value
      3. Infectious Diseases Testing
        1. By Value
      4. Therapeutic Drug Monitoring
        1. By Value
      5. Forensics
        1. By Value
      6. CRO/Research
        1. By Value
    3. By Card Type
      1. Introduction
        1. Card Type By Value
      2. Whatman 903
        1. By Value
      3. Ahlstrom 226
        1. By Value
      4. FTA
        1. By Value
      5. Others
        1. By Value
    4. U.K.
      1. By Application
        1. Introduction
          1. Application By Value
        2. Newborn Screening (NBS)
          1. By Value
        3. Infectious Diseases Testing
          1. By Value
        4. Therapeutic Drug Monitoring
          1. By Value
        5. Forensics
          1. By Value
        6. CRO/Research
          1. By Value
      2. By Card Type
        1. Introduction
          1. Card Type By Value
        2. Whatman 903
          1. By Value
        3. Ahlstrom 226
          1. By Value
        4. FTA
          1. By Value
        5. Others
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Newborn Screening (NBS)
        1. By Value
      3. Infectious Diseases Testing
        1. By Value
      4. Therapeutic Drug Monitoring
        1. By Value
      5. Forensics
        1. By Value
      6. CRO/Research
        1. By Value
    3. By Card Type
      1. Introduction
        1. Card Type By Value
      2. Whatman 903
        1. By Value
      3. Ahlstrom 226
        1. By Value
      4. FTA
        1. By Value
      5. Others
        1. By Value
    4. China
      1. By Application
        1. Introduction
          1. Application By Value
        2. Newborn Screening (NBS)
          1. By Value
        3. Infectious Diseases Testing
          1. By Value
        4. Therapeutic Drug Monitoring
          1. By Value
        5. Forensics
          1. By Value
        6. CRO/Research
          1. By Value
      2. By Card Type
        1. Introduction
          1. Card Type By Value
        2. Whatman 903
          1. By Value
        3. Ahlstrom 226
          1. By Value
        4. FTA
          1. By Value
        5. Others
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Taiwan
    10. South East Asia
    11. Rest of Asia-Pacific
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Newborn Screening (NBS)
        1. By Value
      3. Infectious Diseases Testing
        1. By Value
      4. Therapeutic Drug Monitoring
        1. By Value
      5. Forensics
        1. By Value
      6. CRO/Research
        1. By Value
    3. By Card Type
      1. Introduction
        1. Card Type By Value
      2. Whatman 903
        1. By Value
      3. Ahlstrom 226
        1. By Value
      4. FTA
        1. By Value
      5. Others
        1. By Value
    4. UAE
      1. By Application
        1. Introduction
          1. Application By Value
        2. Newborn Screening (NBS)
          1. By Value
        3. Infectious Diseases Testing
          1. By Value
        4. Therapeutic Drug Monitoring
          1. By Value
        5. Forensics
          1. By Value
        6. CRO/Research
          1. By Value
      2. By Card Type
        1. Introduction
          1. Card Type By Value
        2. Whatman 903
          1. By Value
        3. Ahlstrom 226
          1. By Value
        4. FTA
          1. By Value
        5. Others
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Application
      1. Introduction
        1. Application By Value
      2. Newborn Screening (NBS)
        1. By Value
      3. Infectious Diseases Testing
        1. By Value
      4. Therapeutic Drug Monitoring
        1. By Value
      5. Forensics
        1. By Value
      6. CRO/Research
        1. By Value
    3. By Card Type
      1. Introduction
        1. Card Type By Value
      2. Whatman 903
        1. By Value
      3. Ahlstrom 226
        1. By Value
      4. FTA
        1. By Value
      5. Others
        1. By Value
    4. Brazil
      1. By Application
        1. Introduction
          1. Application By Value
        2. Newborn Screening (NBS)
          1. By Value
        3. Infectious Diseases Testing
          1. By Value
        4. Therapeutic Drug Monitoring
          1. By Value
        5. Forensics
          1. By Value
        6. CRO/Research
          1. By Value
      2. By Card Type
        1. Introduction
          1. Card Type By Value
        2. Whatman 903
          1. By Value
        3. Ahlstrom 226
          1. By Value
        4. FTA
          1. By Value
        5. Others
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Dried Blood Spot Collection Cards Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. CENTOGENE
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Archimedlife
    3. Shimadzu Corporation
    4. Danaher (Pall Corporation)
    5. Qiagen
    6. Perkinelmer
    7. Eastern Business Form
    8. Ahlstrom-Munksjö
    9. F. Hoffmann-La Roche
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

WhatsApp
Chat with us on WhatsApp
Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.